IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 97 filers reported holding IMMUNOVANT INC in Q2 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,985,951 | +527.5% | 807,136 | +210.1% | 0.01% | +500.0% |
| Q2 2023 | $4,938,176 | +7.7% | 260,315 | -12.0% | 0.00% | – |
| Q1 2023 | $4,586,757 | +104.4% | 295,729 | +133.9% | 0.00% | – |
| Q4 2022 | $2,244,470 | +272.2% | 126,449 | +17.1% | 0.00% | – |
| Q3 2022 | $603,000 | -6.1% | 107,964 | -34.4% | 0.00% | – |
| Q2 2022 | $642,000 | -54.9% | 164,518 | -36.3% | 0.00% | – |
| Q1 2022 | $1,422,000 | -79.3% | 258,231 | -68.0% | 0.00% | – |
| Q4 2021 | $6,870,000 | +9.2% | 806,222 | +11.3% | 0.00% | -100.0% |
| Q3 2021 | $6,294,000 | -3.7% | 724,283 | +17.2% | 0.00% | – |
| Q2 2021 | $6,534,000 | +384.4% | 618,171 | +635.1% | 0.00% | – |
| Q1 2021 | $1,349,000 | -15.9% | 84,098 | +142.3% | 0.00% | – |
| Q4 2020 | $1,604,000 | +159.1% | 34,710 | +97.2% | 0.00% | – |
| Q3 2020 | $619,000 | – | 17,602 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |